A study for an effect of the food containing plant-derived ingredient on blood glucose level (SME-2019-01-FOSHUS)
- Conditions
- ot applicable
- Registration Number
- JPRN-UMIN000037444
- Lead Sponsor
- Suntory MONOZUKURI Expert Limited
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 120
Not provided
(1)Subjects who are with treatment. (2)Subjects whose systolic pressure <90 mmHg. (3)Females in pregnancy,lactation and scheduled pregnancy period. (4)Subjects who donated over 200 mL blood components or whole blood within 4 weeks. (5)Male subjects who donated over 400 mL whole blood within 12 weeks. (6)Female who donated over 400 mL whole blood within 16 weeks. (7)Male subjects whose blood was collected more than 1200 mL within the last twelve months when the amount of blood sampling in the current study is added. (8)Female subjects whose blood was collected more than 800 mL within the last twelve months when the amount of blood sampling in the current study is added. (9)Subjects who are participating in other clinical studies,or who finished clinical study within 4 weeks. (10)Subjects who are; (a)With present heart disorder,liver disorder,or kidney disorder. (b)With history of cardiac disorder. (c)With diabetes mellitus. (d)With allergy to drugs or foods. (e)With glaucoma. (f)With hyponatremia. (11)Subjects who constantly use supplements and/or functional foods (including Food for Specified Health Uses) affecting the test results. (12)Subjects who drink alcohol or smoke a lot. (13)Subjects who have an extremely irregular diet habit or alternative work schedule or work on midnight shift. (14)Subjects who experienced unpleasant feeling during drawing blood. (15)Subjects who are deemed to be unsuitable by the investigator.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Efficacy : Blood glucose level after carbohydrate tolerance test Safety : Expression rate of side effects
- Secondary Outcome Measures
Name Time Method